Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Cancer chemoprevention with dietary phytochemicals

Key Points

  • Many population-based studies have highlighted the ability of macronutrients and micronutrients in vegetables and fruit to reduce the risk of cancer. Recently, attention has been focused on phytochemicals — non-nutritive components in the plant-based diet that possess cancer-preventive properties.

  • Despite remarkable progress in our understanding of the carcinogenic process, the mechanisms of action of most chemopreventive phytochemicals have not been fully elucidated.

  • Chemopreventive phytochemicals can block initiation or reverse the promotion stage of multistep carcinogenesis. They can also halt or retard the progression of precancerous cells into malignant ones.

  • Many molecular alterations associated with carcinogenesis occur in cell-signalling pathways that regulate cell proliferation and differentiation. One of the central components of the intracellular-signalling network that maintains homeostasis is the family of mitogen-activated protein kinases (MAPKs).

  • Numerous intracellular signal-transduction pathways converge with the activation of the transcription factors NF-κB and AP1. As these factors mediate pleiotropic effects of both external and internal stimuli in the cellular-signalling cascades, they are prime targets of diverse classes of chemopreventive phytochemicals.

  • Basic helix–loop–helix transcription factors such as NRF2 regulate expression of phase II enzymes, which detoxify carcinogens and protect against oxidative stress. A number of phytochemicals have been shown to induce expression of phase II enzymes via NRF2.

  • β-Catenin, a multifunctional protein that was originally identified as a component of cell–cell adhesion machinery, is another important molecular target for chemoprevention. Several dietary phytochemicals have been shown to target this molecule.

Abstract

Chemoprevention refers to the use of agents to inhibit, reverse or retard tumorigenesis. Numerous phytochemicals derived from edible plants have been reported to interfere with a specific stage of the carcinogenic process. Many mechanisms have been shown to account for the anticarcinogenic actions of dietary constituents, but attention has recently been focused on intracellular-signalling cascades as common molecular targets for various chemopreventive phytochemicals.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Dietary phytochemicals that block or suppress multistage carcinogenesis.
Figure 2
Figure 3: Effect of phytochemicals on activation of NF-κB and AP1.
Figure 4: Transcriptional activation by NRF2.
Figure 5: Effect of phytochemicals on β-catenin signalling.

References

  1. Doll, R. & Peto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst. 66, 1191–1308 (1981).

    Article  CAS  PubMed  Google Scholar 

  2. Greenwald, P. Chemoprevention of cancer. Sci. Am. 275, 96–99 (1996).

    Article  CAS  PubMed  Google Scholar 

  3. Wattenberg, L. W. Chemoprevention of cancer. Cancer Res. 45, 1–8 (1985).

    Article  CAS  PubMed  Google Scholar 

  4. Manson, M. M. Cancer prevention: the potential for diet to modulate molecular signalling. Trends Mol. Med. 9, 11–18 (2003). This seminal review (together with reference 11) discusses the dietary modulation of several key signalling cascades from mechanistic viewpoints.

    Article  CAS  PubMed  Google Scholar 

  5. Milner, J. A., McDonald, S. S., Anderson, D. E. & Greenwald, P. Molecular targets for nutrients involved with cancer prevention. Nutr. Cancer 41, 1–16 (2001).

    CAS  PubMed  Google Scholar 

  6. Gescher, A., Pastorino, U., Plummer, S. M. & Manson, M. M. Suppression of tumour development by substances derived from the diet: mechanisms and clinical implications. Br. J. Clin. Pharmacol. 45, 1–12 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ashendel, C. L. Diet, signal transduction and carcinogenesis. J. Nutr. 125, 686S–691S (1995).

    CAS  PubMed  Google Scholar 

  8. Kong, A. N. et al. Signal transduction events elicited by cancer prevention compounds. Mutat. Res. 480–481, 231–241 (2001).

    Article  PubMed  Google Scholar 

  9. Agarwal, R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem. Pharmacol. 60, 1051–1059 (2000).

    Article  CAS  PubMed  Google Scholar 

  10. Bode, A. M. & Dong, Z. Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol. 1, 181–188 (2000).

    Article  CAS  PubMed  Google Scholar 

  11. Manson, M. M. et al. Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol. Lett. 112–113, 499–505 (2000).

    Article  PubMed  Google Scholar 

  12. Owuor, E. D. & Kong, A. N. Antioxidants and oxidants regulated signal transduction pathways. Biochem. Pharmacol. 64, 765–770 (2002).

    Article  CAS  PubMed  Google Scholar 

  13. Beg, A. A. & Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782–784 (1996).

    Article  CAS  PubMed  Google Scholar 

  14. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. & Baldwin, A. S. Jr. NF-kB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680–1683 (1998).

    Article  CAS  PubMed  Google Scholar 

  15. Visconti, R. et al. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression. Oncogene 15, 1987–1994 (1997).

    Article  CAS  PubMed  Google Scholar 

  16. Bharti, A. C. & Aggarwal, B. B. Nuclear factor-κ B and cancer: its role in prevention and therapy. Biochem. Pharmacol. 64, 883–888 (2002).

    Article  CAS  PubMed  Google Scholar 

  17. Bremner, P. & Heinrich, M. Natural products as targeted modulators of the nuclear factor-κB pathway. J. Pharm. Pharmacol. 54, 453–472 (2002).

    Article  CAS  PubMed  Google Scholar 

  18. Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M. & Colburn, N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl Acad. Sci. USA 91, 609–613 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Dong, Z., Lavrovsky, V. & Colburn, N. H. Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis 16, 749–756 (1995).

    Article  CAS  PubMed  Google Scholar 

  20. Dong, Z., Huang, C., Brown, R. E. & Ma, W. Y. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J. Biol. Chem. 272, 9962–9970 (1997).

    Article  CAS  PubMed  Google Scholar 

  21. Huang, C., Ma, W. Y., Young, M. R., Colburn, N. & Dong, Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl Acad. Sci. USA 95, 156–161 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Huang, C., Ma, W. Y. & Dong, Z. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol. Cell. Biol. 16, 6427–6435 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Watts, R. G. et al. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene 17, 3493–3498 (1998). A crucial role of AP1 in malignant transformation, especially in the stage of tumour promotion, has been demonstrated in references 18–23. The signalling pathways that mediate AP1 activation have also been proposed in references 21–23.

    Article  CAS  PubMed  Google Scholar 

  24. Plummer, S. M. et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex. Oncogene 18, 6013–6020 (1999).

    Article  CAS  PubMed  Google Scholar 

  25. Surh, Y. J., Han, S. S., Keum, Y. S., Seo, H. J. & Lee, S. S. Inhibitory effects of curcumin and capsaicin on phorbol ester-induced activation of eukaryotic transcription factors, NF-κB and AP-1. Biofactors 12, 107–112 (2000).

    Article  CAS  PubMed  Google Scholar 

  26. Chun, K. S. et al. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF–κB activation. Carcinogenesis 24, 1515–1524 (2003).

    Article  CAS  PubMed  Google Scholar 

  27. Singh, S. & Aggarwal, B. B. Activation of transcription factor NF-κ B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270, 24995–25000 (1995).

    Article  CAS  PubMed  Google Scholar 

  28. Bharti, A. C., Donato, N., Singh, S. & Aggarwal, B. B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κ B and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053–1062 (2003).

    Article  CAS  PubMed  Google Scholar 

  29. Philip, S. & Kundu, G. C. Osteopontin induces nuclear factor κB-mediated promatrix metalloproteinase-2 activation through IκBα/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J. Biol. Chem. 278, 14487–14497 (2003).

    Article  CAS  PubMed  Google Scholar 

  30. Park, K. K., Chun, K. S., Lee, J. M., Lee, S. S. & Surh, Y. J. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett. 129, 139–144 (1998).

    Article  CAS  PubMed  Google Scholar 

  31. Bode, A. M., Ma, W. Y., Surh, Y. J. & Dong, Z. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res. 61, 850–853 (2001).

    CAS  PubMed  Google Scholar 

  32. Surh, Y. J. & Lee, S. S. Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci. 56, 1845–1855 (1995).

    Article  CAS  PubMed  Google Scholar 

  33. Surh, Y. J. & Lee, S. S. Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen? Food Chem. Toxicol. 34, 313–316 (1996).

    Article  CAS  PubMed  Google Scholar 

  34. Surh, Y. J. et al. Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis 16, 2467–2471 (1995).

    Article  CAS  PubMed  Google Scholar 

  35. Surh, Y. J. More than spice: capsaicin in hot chili peppers makes tumor cells commit suicide. J. Natl Cancer Instit. 94, 1263–1265 (2002).

    Article  CAS  Google Scholar 

  36. Park, K. K., Chun, K. S., Yook, J. I. & Surh, Y. J. Lack of tumor promoting activity of capsaicin, a principal pungent ingredient of red pepper, in mouse skin carcinogenesis. Anticancer Res. 18, 4201–4205 (1998).

    CAS  PubMed  Google Scholar 

  37. Han, S. S. et al. Capsaicin suppresses phorbol ester-induced activation of NF-κB/Rel and AP-1 transcription factors in mouse epidermis. Cancer Lett. 164, 119–126 (2001).

    Article  CAS  PubMed  Google Scholar 

  38. Han, S. S., Keum, Y. S., Chun, K. S. & Surh, Y. J. Suppression of phorbol ester-induced NF-κB activation by capsaicin in cultured human promyelocytic leukemia cells. Arch. Pharm. Res. 25, 475–479 (2002).

    Article  CAS  PubMed  Google Scholar 

  39. Patel, P. S., Varney, M. L., Dave, B. J. & Singh, R. K. Regulation of constitutive and induced NF-κB activation in malignant melanoma cells by capsaicin modulates interleukin-8 production and cell proliferation. J. Interferon Cytokine Res. 22, 427–435 (2002).

    Article  CAS  PubMed  Google Scholar 

  40. Macho, A., Blazquez, M. V., Navas, P. & Munoz, E. Induction of apoptosis by vanilloid compounds does not require de novo gene transcription and activator protein 1 activity. Cell Growth Differ. 9, 277–286 (1998).

    CAS  PubMed  Google Scholar 

  41. Kang, H. J. et al. Roles of JNK-1 and p38 in selective induction of apoptosis by capsaicin in ras-transformed human breast epithelial cells. Int. J. Cancer 103, 475–482 (2003).

    Article  CAS  PubMed  Google Scholar 

  42. Dong, Z., Ma, W., Huang, C. & Yang, C. S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (−)-epigallocatechin gallate, and theaflavins. Cancer Res. 57, 4414–4419 (1997).

    CAS  PubMed  Google Scholar 

  43. Nomura, M. et al. Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea. Mol. Carcinog. 28, 148–155 (2000).

    Article  CAS  PubMed  Google Scholar 

  44. Nomura, M., Ma, W., Chen, N., Bode, A. M. & Dong, Z. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-κB activation by tea polyphenols, (−)-epigallocatechin gallate and theaflavins. Carcinogenesis 21, 1885–1890 (2000).

    Article  CAS  PubMed  Google Scholar 

  45. Afaq, F., Adhami, V. M., Ahmad, N. & Mukhtar, H. Inhibition of ultraviolet B-mediated activation of nuclear factor κB in normal human epidermal keratinocytes by green tea Constituent (−)-epigallocatechin-3-gallate. Oncogene 22, 1035–1044 (2003).

    Article  CAS  PubMed  Google Scholar 

  46. Chung, J. Y., Huang, C., Meng, X., Dong, Z. & Yang, C. S. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res. 59, 4610–4617 (1999). Provides the evidence for specific mechanisms of inhibition of the Mapk signalling pathway by tea polyphenols, including EGCG, as the molecular basis of their antineoplastic effects.

    CAS  PubMed  Google Scholar 

  47. Yang, G. Y. et al. Effect of black and green tea polyphenols on c-jun phosphorylation and H2O2 production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 21, 2035–2039 (2000).

    Article  CAS  PubMed  Google Scholar 

  48. Nomura, M., Kaji, A., Ma, W., Miyamoto, K. & Dong, Z. Suppression of cell transformation and induction of apoptosis by caffeic acid phenethyl ester. Mol. Carcinog. 31, 83–89 (2001).

    Article  CAS  PubMed  Google Scholar 

  49. Pianetti, S., Guo, S., Kavanagh, K. T. & Sonenshein, G. E. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 62, 652–655 (2002).

    CAS  PubMed  Google Scholar 

  50. Masuda, M. et al. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J. Exp. Ther. Oncol. 2, 350–359 (2002).

    Article  CAS  PubMed  Google Scholar 

  51. Ahmad, N., Gupta, S. & Mukhtar, H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor κB in cancer cells versus normal cells. Arch. Biochem. Biophys. 376, 338–346 (2000).

    Article  CAS  PubMed  Google Scholar 

  52. Lin, J. K., Liang, Y. C. & Lin-Shiau, S. Y. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem. Pharmacol. 58, 911–915 (1999).

    Article  CAS  PubMed  Google Scholar 

  53. Lin, J. K. Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch. Pharm. Res. 25, 561–571 (2002).

    Article  CAS  PubMed  Google Scholar 

  54. Dampier, K. et al. Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br. J. Cancer 85, 618–624 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Tacchini, L., Dansi, P., Matteucci, E. & Desiderio, M. A. Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2. Exp. Cell Res. 256, 272–281 (2000).

    Article  CAS  PubMed  Google Scholar 

  56. Wang, Y., Zhang, X., Lebwohl, M., DeLeo, V. & Wei, H. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis 19, 649–654 (1998).

    Article  CAS  PubMed  Google Scholar 

  57. Davis, J. N., Kucuk, O. & Sarkar, F. H. Genistein inhibits NF-κB activation in prostate cancer cells. Nutr. Cancer 35, 167–174 (1999).

    Article  CAS  PubMed  Google Scholar 

  58. Li, Y. & Sarkar, F. H. Inhibition of nuclear factor κB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin. Cancer Res. 8, 2369–2377 (2002).

    CAS  PubMed  Google Scholar 

  59. Gong, L., Li, Y., Nedeljkovic-Kurepa, A. & Sarkar, F. H. Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 22, 4702–4709 (2003). This study addresses a possible crosstalk between NF-κB and AKT signalling pathways, which are targets of antiproliferative activity exerted by genistein in human mammary carcinoma cells.

    Article  CAS  PubMed  Google Scholar 

  60. Chen, C. C., Sun, Y. T., Chen, J. J. & Chiu, K. T. TNF-α-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-γ 2, protein kinase C-α, tyrosine kinase, NF-κ B-inducing kinase, and I-κ B kinase 1/2 pathway. J. Immunol. 165, 2719–2728 (2000).

    Article  CAS  PubMed  Google Scholar 

  61. Nasuhara, Y., Adcock, I. M., Catley, M., Barnes, P. J. & Newton, R. Differential IκB kinase activation and IκBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells. Evidence for additional regulatory steps in κB-dependent transcription. J. Biol. Chem. 274, 19965–19972 (1999).

    Article  CAS  PubMed  Google Scholar 

  62. Subbaramaiah, K. et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273, 21875–21882 (1998). This paper provides the first evidence for the inhibitory effects of resveratrol on the transcription and activity of COX2 by targeting CRE and PKC.

    Article  CAS  PubMed  Google Scholar 

  63. Subbaramaiah, K. et al. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Ann. NY Acad. Sci. 889, 214–223 (1999).

    Article  CAS  PubMed  Google Scholar 

  64. Mouria, M. et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer 98, 761–769 (2002).

    Article  CAS  PubMed  Google Scholar 

  65. Banerjee, S., Bueso-Ramos, C. & Aggarwal, B. B. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62, 4945–4954 (2002).

    CAS  PubMed  Google Scholar 

  66. Narayanan, B. A., Narayanan, N. K., Re, G. G. & Nixon, D. W. Differential expression of genes induced by resveratrol in LNCaP cells: p53-mediated molecular targets. Int. J. Cancer 104, 204–212 (2003).

    Article  CAS  PubMed  Google Scholar 

  67. She, Q. B., Bode, A. M., Ma, W. Y., Chen, N. Y. & Dong, Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61, 1604–1610 (2001).

    CAS  PubMed  Google Scholar 

  68. Yu, R. et al. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways. Mol. Pharmacol. 60, 217–224 (2001).

    Article  CAS  PubMed  Google Scholar 

  69. Adhami, V. M., Afaq, F. & Ahmad, N. Suppression of ultraviolet B exposure-mediated activation of NF-κB in normal human keratinocytes by resveratrol. Neoplasia 5, 74–82 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Manna, S. K., Mukhopadhyay, A. & Aggarwal, B. B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κ B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164, 6509–6519 (2000).

    Article  CAS  PubMed  Google Scholar 

  71. Holmes-McNary, M. & Baldwin, A. S. Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res. 60, 3477–3483 (2000).

    CAS  PubMed  Google Scholar 

  72. Hayes, J. D. & McMahon, M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 174, 103–113 (2001).

    Article  CAS  PubMed  Google Scholar 

  73. Itoh, K. et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313–322 (1997). A pioneering study elucidating an essential role of NRF2 in the transcriptional induction of phase II enzymes. Targeted disruption of the Nrf2 gene abolished phase II enzyme induction (this paper) and Nrf2-deficient mice are prone to chemically-induced carcinogenesis (references 75 and 84).

    Article  CAS  PubMed  Google Scholar 

  74. Kwak, M. K. et al. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 278, 8135–8145 (2003).

    Article  CAS  PubMed  Google Scholar 

  75. Ramos-Gomez, M. et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl Acad. Sci. USA 98, 3410–3415 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Chan, K., Han, X. D. & Kan, Y. W. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl Acad. Sci. USA 98, 4611–4616 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. McMahon, M. et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61, 3299–3307 (2001).

    CAS  PubMed  Google Scholar 

  78. Cho, H. Y. et al. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26, 175–182 (2002).

    Article  CAS  PubMed  Google Scholar 

  79. Chanas, S. A. et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. 365, 405–416 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Thimmulappa, R. K. et al. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62, 5196–5203 (2002).

    CAS  PubMed  Google Scholar 

  81. Enomoto, A. et al. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59, 169–177 (2001).

    Article  CAS  PubMed  Google Scholar 

  82. Ishii, T. et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275, 16023–16029 (2000).

    Article  CAS  PubMed  Google Scholar 

  83. Chan, K. & Kan, Y. W. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl Acad. Sci. USA 96, 12731–12736 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Ramos-Gomez, M., Dolan, P. M., Itoh, K., Yamamoto, M. & Kensler, T. W. Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice. Carcinogenesis 24, 461–467 (2003).

    Article  CAS  PubMed  Google Scholar 

  85. Kwak, M. K. et al. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat. Res. 480–481, 305–315 (2001).

    Article  PubMed  Google Scholar 

  86. Alam, J. et al. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274, 26071–26078 (1999).

    Article  CAS  PubMed  Google Scholar 

  87. Chan, J. Y. & Kwong, M. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim. Biophys. Acta 1517, 19–26 (2000).

    Article  CAS  PubMed  Google Scholar 

  88. Nguyen, T., Huang, H. C. & Pickett, C. B. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J. Biol. Chem. 275, 15466–15473 (2000).

    Article  CAS  PubMed  Google Scholar 

  89. Itoh, K. et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76–86 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Dinkova-Kostova, A. T., Massiah, M. A., Bozak, R. E., Hicks, R. J. & Talalay, P. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc. Natl Acad. Sci. USA 98, 3404–3409 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Dinkova-Kostova, A. T. et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Nat. Acad. Sci. USA 99, 11908–11913 (2002). This work provides the first direct evidence for the formation of complexes of KEAP1 with the NEH2 domain of NRF2, which is disrupted by phase II enzyme inducers, such as sulphoraphane. Sulphoraphane directly reacts with critical cysteine residues of KEAP1 stoichiometrically.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Wolf, C. R. Chemoprevention: increased potential to bear fruit. Proc. Natl Acad. Sci. USA 98, 2941–2943 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Na, H. -K. & Surh, Y. -J. Peroxisome proliferator–activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation. Biochem. Pharmacol. 66, 1381–1391 (2003).

    Article  CAS  PubMed  Google Scholar 

  94. Yu, R. et al. Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis 18, 451–456 (1997). Here, the molecular basis for induction of phase II enzymes by green-tea polyphenol was demonstrated. Green-tea polyphenol stimulates transcription of phase II enzymes through ARE, which seems to be regulated by MAPK.

    Article  CAS  PubMed  Google Scholar 

  95. Chen, C., Yu, R., Owuor, E. D. & Kong, A. N. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res. 23, 605–612 (2000).

    Article  CAS  PubMed  Google Scholar 

  96. Kong, A. N. et al. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). Drug Metab. Rev. 33, 255–271 (2001).

    Article  CAS  PubMed  Google Scholar 

  97. Yu, R. et al. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem. 274, 27545–27552 (1999).

    Article  CAS  PubMed  Google Scholar 

  98. Morimitsu, Y. et al. A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J. Biol. Chem. 277, 3456–3463 (2002).

    Article  CAS  PubMed  Google Scholar 

  99. Balogun, E. et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 371, 887–895 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Dickinson, D. A., Iles, K. E., Zhang, H., Blank, V. & Forman, H. J. Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. FASEB J. 17, 473–475 (2003).

    Article  CAS  PubMed  Google Scholar 

  101. Kemler, R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 9, 317–321 (1993).

    Article  CAS  PubMed  Google Scholar 

  102. Aberle, H., Schwartz, H. & Kemler, R. Cadherin-catenin complex: protein interactions and their implications for cadherin function. J. Cell Biochem. 61, 514–523 (1996).

    Article  CAS  PubMed  Google Scholar 

  103. Morin, P. J. β-catenin signaling and cancer. Bioessays 21, 1021–1030 (1999).

    Article  CAS  PubMed  Google Scholar 

  104. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B. & Polakis, P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl Acad. Sci. USA 92, 3046–3050 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Rubinfeld, B. et al. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 272, 1023–1026 (1996). This important paper provides evidence for the role of GSK-3β as a regulator of APC β-catenin binding. APC is a good substrate for GSK.

    Article  CAS  PubMed  Google Scholar 

  106. Orford, K., Crockett, C., Jensen, J. P., Weissman, A. M. & Byers, S. W. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem. 272, 24735–24738 (1997).

    Article  CAS  PubMed  Google Scholar 

  107. Sakanaka, C. Phosphorylation and regulation of β-catenin by casein kinase I epsilon. J. Biochem. 132, 697–703 (2002).

    Article  CAS  PubMed  Google Scholar 

  108. Amit, S. et al. Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 16, 1066–1076 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Liu, C. et al. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837–847 (2002).

    Article  CAS  PubMed  Google Scholar 

  110. Grimes, C. A. & Jope, R. S. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog. Neurobiol. 65, 391–426 (2001).

    Article  CAS  PubMed  Google Scholar 

  111. Polakis, P. Wnt signaling and cancer. Genes Dev. 14, 1837–1851 (2000).

    CAS  PubMed  Google Scholar 

  112. Satoh, S. et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nature Genet. 24, 245–250 (2000).

    Article  CAS  PubMed  Google Scholar 

  113. Novak, A. & Dedhar, S. Signaling through β-catenin and Lef/Tcf. Cell Mol. Life Sci. 56, 523–537 (1999).

    Article  CAS  PubMed  Google Scholar 

  114. Wong, N. A. & Pignatelli, M. β-catenin: a linchpin in colorectal carcinogenesis? Am. J. Pathol. 160, 389–401 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Kolligs, F. T. et al. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation. Cancer Cell 1, 145–155 (2002).

    Article  CAS  PubMed  Google Scholar 

  116. Araki, Y. et al. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res. 63, 728–734 (2003).

    CAS  PubMed  Google Scholar 

  117. Mahmoud, N. N. et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21, 921–927 (2000).

    Article  CAS  PubMed  Google Scholar 

  118. Jaiswal, A. S., Marlow, B. P., Gupta, N. & Narayan, S. β-catenin-mediated transactivation and cell–cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21, 8414–8427 (2002).

    Article  CAS  PubMed  Google Scholar 

  119. Joe, A. K. et al. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8, 893–903 (2002).

    CAS  PubMed  Google Scholar 

  120. Dashwood, W. M., Orner, G. A. & Dashwood, R. H. Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations. Biochem. Biophys. Res. Commun. 296, 584–588 (2002).

    Article  CAS  PubMed  Google Scholar 

  121. Orner, G. A. et al. Response of Apcmin and A33ΔNβ-cat mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mutat. Res. 506–507, 121–127 (2002).

    Article  PubMed  Google Scholar 

  122. Blum, C. A. et al. β-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis 22, 315–320 (2001).

    Article  CAS  PubMed  Google Scholar 

  123. Meng, Q. et al. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J. Mol. Med. 78, 155–165 (2000).

    Article  CAS  PubMed  Google Scholar 

  124. Brack, M. E. et al. The citrus methoxyflavone tangeretin affects human cell–cell interactions. Adv. Exp. Med. Biol. 505, 135–139 (2002).

    Article  PubMed  Google Scholar 

  125. McEntee, M. F., Chiu, C. H. & Whelan, J. Relationship of β-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice. Carcinogenesis 20, 635–640 (1999).

    Article  CAS  PubMed  Google Scholar 

  126. Dihlmann, S., Siermann, A. & von Knebel Doeberitz, M. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling. Oncogene 20, 645–653 (2001).

    Article  CAS  PubMed  Google Scholar 

  127. Mori, H. et al. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of β-catenin-accumulated crypts as a new biomarker. Eur. J. Cancer Prev. 11 (Suppl. 2), S71–S75 (2002).

    PubMed  Google Scholar 

  128. Surh, Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mut. Res. 428, 305–327 (1999).

    Article  CAS  Google Scholar 

  129. Das, R., Mahabeleshwar, G. H. & Kundu, G. C. Osteopontin stimulates cell motility and nuclear factor κB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3–kinase/Akt signaling pathways in breast cancer cells. J. Biol. Chem. (in the press).

  130. Yang, F. et al. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-κB activation by inhibiting Iκ B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharm. 60, 528–533 (2001).

    Article  CAS  Google Scholar 

  131. Huang, H. C., Nguyen, T. & Pickett, C. B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277, 42769–42774 (2002).

    Article  CAS  PubMed  Google Scholar 

  132. Kang, K. W., Park, E. Y. & Kim, S. G. Activation of CCAAT/enhancer-binding protein β by 2'-amino-3'-methoxyflavone (PD98059) leads to the induction of glutathione S-transferase A2. Carcinogenesis 24, 475–482 (2003).

    Article  CAS  PubMed  Google Scholar 

  133. Lee, J. M., Hanson, J. M., Chu, W. A. & Johnson, J. A. Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. J. Biol. Chem. 276, 20011–20016 (2001).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The author thanks the members of his laboratory, especially H.K. Na, J.K. Kundu, K.S. Chun, J.S. Lee, M.H. Chung, E. Kim and J.M. Lee (currently at the University of Wisconsin-Madison) for having prepared the table and illustrations, as well as sorting out the references. Work in the author's laboratory is supported by research grants from the Korea Institute of Science and Technology Evaluation and Planning (KISTEP) for functional food research and development, Ministry of Science and Technology.

Author information

Authors and Affiliations

Authors

Supplementary information

Related links

Related links

DATABASES

LocusLink

β-catenin

AKT

APAF1

APC

CBP

CKI

COX2

Egf

ERBB2

ERK2

FOS

GSK-3β

GST

HO-1

HRAS

IκB

JNK

JUN

KEAP1

NF-κB

NRF1

NRF2

p300

p38

p53

PI3K

PKC

STAT3

TNF-α

VEGF

WAF1

γ-GCS

FURTHER INFORMATION

1997 World Cancer Research Fund and AICR report

'Five A Day for Better Health' report

Glossary

LUCIFERASE-REPORTER-GENE ASSAY

A recombinant method that is used to measure transcriptional activity in which the regulatory sequence (for example, promoter or enhancer) of interest is joined to a firefly luciferase gene that, following activation, produces light from luciferin in the presence of ATP added to the assay mixture. The relative intensity of the light emission is measured with a luminometer.

CREB

(Cyclic AMP response element binding protein). CREB is a leucine zipper transcription factor that binds to DNA at the cyclic AMP response element (CRE) as a homo- or heterodimer. It has pivotal roles in the control of cellular proliferation and differentiation, apoptosis, intermediary metabolism, inflammation and numerous other responses, particularly in hepatocytes, adipocytes and haematopoietic cells.

PHASE II ENZYMES

A group of xenobiotic metabolizing enzymes that are mainly involved in the inactivation and excretion of carcinogens and other toxic chemical substances.

ANTIOXIDANT-RESPONSIVE ELEMENT

(ARE). A specific DNA-promoter-binding region that can be transcriptionally activated by numerous antioxidants and/or electrophiles. Many stress-response genes encoding phase II detoxification or antioxidant enzymes such as glutathione S-transferase, quinone reductase, and heme oxygenase-1 — which provide defence against cellular oxidative stress — have this element in their 5′-flanking region to facilitate the transcription process.

REDOX CYCLING

A reciprocal transformation between an oxidant and its reductive counterpart. An example is conversion of catechol to quinone via semiquinone or vice versa.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Surh, YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768–780 (2003). https://doi.org/10.1038/nrc1189

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrc1189

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing